ArticleFrontiers in pharmacology2022

Ruthenium complexes show potent inhibition of AKR1C1, AKR1C2, and AKR1C3 enzymes and anti-proliferative action against chemoresistant ovarian cancer cell line.

Jakob Kljun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.